(Q46598564)

23 December 2017

title

Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism (English)

1 reference

23 December 2017

chronic lymphocytic leukemia

0 references

1 reference

1 reference

R F Dielschneider

1

1 reference

23 December 2017

H Eisenstat

2

1 reference

23 December 2017

S Mi

3

1 reference

23 December 2017

J M Curtis

4

1 reference

23 December 2017

W Xiao

5

1 reference

23 December 2017

J B Johnston

6

1 reference

23 December 2017

S B Gibson

7

1 reference

23 December 2017

publication date

3 February 2016

1 reference

23 December 2017

published in

Leukemia

1 reference

23 December 2017

volume

30

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

1290-1300

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2016.4

exact match

0 references

cites work

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Obinutuzumab (GA101) in relapsed/refractory chronic lymphocytic leukemia: final data from the phase 1/2 GAUGUIN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Re-configuration of sphingolipid metabolism by oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Decreased deformability of lymphocytes in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Effects of ceramide and other simple sphingolipids on membrane lateral structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Membranes in balance: mechanisms of sphingolipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

The B-cell receptor signaling pathway as a therapeutic target in CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Structure and function of sphingolipid- and cholesterol-rich membrane rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Siramesine triggers cell death through destabilisation of mitochondria, but not lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Lysosomal cell death at a glance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Lysosome: regulator of lipid degradation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Sphingolipid metabolic pathway: an overview of major roles played in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

The mitochondrial permeability transition pore (PTP) - an example of multiple molecular exaptation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Physiological roles of the permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Electrophysiology of the inner mitochondrial membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Dysregulation of sphingolipid metabolism in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

MicroRNA-101 down-regulates sphingosine kinase 1 in colorectal cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Sphingosine mediates TNFα-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Sphingosine-induced apoptosis is dependent on lysosomal proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.4

Plasma concentrations of tricyclic antidepressants in clinical practice

21 January 2018

1 reference

12 December 2020

CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101

1 reference

12 December 2020

Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells

1 reference

12 December 2020

Lysosomes as targets for cancer therapy

1 reference

12 December 2020

Human B lymphocytes show greater susceptibility to H2O2 toxicity than T lymphocytes.

1 reference

12 December 2020

Sphingosine kinase 1 is up-regulated in colon carcinogenesis

1 reference

12 December 2020

Siramesine H Lundbeck

1 reference

12 December 2020

Reduced tocopherol content of B cells from patients with chronic lymphocytic leukemia

1 reference

12 December 2020

A gene network regulating lysosomal biogenesis and function

1 reference

12 December 2020

Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2016.4

1 reference

23 December 2017

Dimensions Publication ID

1019548505

0 references

1 reference

23 December 2017